This is the classic website, which will be retired eventually. Please visit the modernized ClinicalTrials.gov instead.
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

PMCF Study of LiquiBand FIX8® OHMF Device (LBF8-Open)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT04059640
Recruitment Status : Recruiting
First Posted : August 16, 2019
Last Update Posted : September 6, 2023
Sponsor:
Collaborator:
Imarc Research, Inc.
Information provided by (Responsible Party):
Advanced Medical Solutions Ltd.

Study Description
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information
Brief Summary:
Study to evaluate the safety and performance of LiquiBand FIX8® Open Hernia Mesh Fixation Device.

Condition or disease Intervention/treatment Phase
Inguinal Hernia Device: LiquiBand FIX8 Open Hernia Mesh Fixation Device Not Applicable

Study Design
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 107 participants
Allocation: N/A
Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: PMCF Study to Evaluate the Safety and Performance of LiquiBand FIX8® Open Hernia Mesh Fixation Device
Actual Study Start Date : December 7, 2021
Estimated Primary Completion Date : May 2025
Estimated Study Completion Date : August 2025

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Hernia

Arms and Interventions
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Arm Intervention/treatment
Experimental: LiquiBand FIX8® OHMF Device
Subjects will undergo hernia mesh fixation and topical wound closure using the LiquiBand FIX8® OHMF device.
 Device: LiquiBand FIX8 Open Hernia Mesh Fixation Device

Subjects will undergo hernia mesh fixation and topical wound closure using the LiquiBand FIX8® OHMF device.

Subjects will be evaluated intra-operatively, post-operatively, at discharge, and at 12 months post-operatively. The Liquiband surgical study device is considered a permanent implant.


Outcome Measures
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Primary Outcome Measures :
  1. Effectiveness of the LiquiBand FIX8 OHMF device [ Time Frame: Time of surgery ]
    Effectiveness will be defined as successful fixation of the hernia mesh (ie not requiring additional fixation by an alternate device) using the LiquiBand FIX8 device at the time of surgery. Based on data pooled from published studies of a similar device (which employs the same cyanoacrylate glue to fix hernia mesh, via a laparoscopic rather than open surgical approach), there has been an observed failure rate of 0.8% in mesh fixation. This study aims to demonstrate non-inferiority of the LiquiBand FIX8 device to a failure rate of 5% (medically acceptable inference).


Secondary Outcome Measures :
  1. Safety of the LiquiBand FIX8 OHMF device [ Time Frame: 0 (intra-operatively), up to 2 days (discharge from hospital) and 12-months post surgery ]

    The incidence of adverse events (whether or not determined to be related to the LiquiBand FIX8 Device) will be recorded. Complications assessed during the study will include:

    • Haematoma
    • Seroma
    • Testicular ischaemia and atrophy
    • Surgical site or wound infection/dehiscence
    • Mesh infection
    • Chronic post-operative pain (lasting ≥ 12 months post-surgery

  2. Effectiveness of the LiquiBandFIX8 OHMF device for topical wound closure [ Time Frame: Time of surgery ]
    Defined as successful closure of the incision site using the LiquiBand FIX8 Device (not requiring additional fixation by an alternate device).

  3. Assessment of chronic post-operative pain using the Visual Analogue Scale: the minimal clinically important difference and patient acceptable symptom state. [ Time Frame: 12-months post-surgery ]

    Chronic post-operative pain will be assessed using the following measures:

    • Improvement in post-operative pain from baseline to 12 months post-surgery as measured by the Visual Analogue Scale (0 = no pain to 10 = most pain imaginable); and
    • Analgesic requirements in the 12 months post-surgery

  4. Long term performance of the study device [ Time Frame: 12-months post surgery ]
    Long-term performance will be assessed by rate of hernia recurrence.

  5. Comparison of cost-effectiveness of patients treated with the LiquiBand FIX8 OHMF device compared with costs for those treated using standard surgical technique. [ Time Frame: 12-months ]
    A study-specific outcome model will be used, which will calculate an incremental cost effectiveness ratio (ICER) in terms of quality-adjusted life years (QALYs) achieved with the introduction of the LiquiBand FIX8 OHMF device compared with using a standard surgical technique (suture fixation).

  6. Comparison of costs of patients' clinical events treated with the LiquiBand FIX8 OHMF device compared with costs for those treated using standard surgical technique. [ Time Frame: 12-months ]
    A study-specific outcome model will be used which will calculate an incremental cost effectiveness ratio (ICER) given in terms of clinical events avoided achieved with the introduction of the LiquiBand FIX8 OHMF device compared with using a standard surgical technique (suture fixation).

  7. Clinician satisfaction [ Time Frame: 0 (Post Surgery) and upto 2 days (hospital discharge) ]
    Users will be asked to rate the device on factors relating to ease of use and satisfaction, compared with their experience of other hernia mesh fixation devices. Satisfaction will be assessed using a Likert-type scale (e.g. Very satisfied (1), Satisfied (2), Neither (3), Dissatisfied (4), Very dissatisfied (5))


Other Outcome Measures:
  1. Cosmesis of wound closure using the Visual Analogue Scale [ Time Frame: 12-months ]
    Cosmesis of the wound closure will be assessed by the investigator and patient, and measured by Visual Analogue Scale (0 = Very poor cosmetic outcome; to 10 = very good cosmetic outcome).


Eligibility Criteria
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Subject is able to understand and give informed consent to take part in the study
  • Subject has a primary inguinal hernia.
  • Subject is scheduled to undergo open inguinal hernia repair using the LiquiBand FIX8® OHMF device.
  • Subject is willing and able to comply with the protocol assessments at time of surgery and during the post-surgical follow-up period.

Exclusion Criteria:

  • Subject is undergoing open repair surgery for recurrent hernia, where the primary surgery was also open. Subjects with recurrent hernia whose primary surgery was laparoscopic are not excluded.
  • Subject has an anatomical defect or had prior surgical procedures that in the opinion of the investigator makes them unsuitable for open hernia repair with the LiquiBand FIX8® OHMF device.
  • Subject is known to be non-compliant with medical treatment.
  • Subject is pregnant or actively breastfeeding.
  • Subject has any significant or unstable medical or psychiatric condition that, in the opinion of the Investigator, would interfere with his/her ability to participate in the study.
  • Subject has a known sensitivity to cyanoacrylate or formaldehyde, D&C Violet No.2 dye or any other component of LiquiBand FIX8® OHMF device.
  • The hernia mesh to be used in the repair is constructed from Polytetrafluoroethylene (PTFE) or absorbable materials.
  • The hernia mesh to be used in the repair is a self-gripping mesh (e.g. ProGrip).
  • Subject has active or potential infection at the surgical site.
  • Subject has a history of keloid formation.
  • Subject has a known vitamin C or zinc deficiency.
  • Subject has a connective tissue disorder.
Contacts and Locations
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04059640


Contacts
Layout table for location contacts
Contact: Tina Warburton 01606863500 tina.warburton@admedsol.com
Contact: Rebecca Forder 01606863500 rebecca.forder@admedsol.com

Locations
Layout table for location information
United Kingdom
Tameside General Hospital Recruiting
Ashton-under-Lyne, United Kingdom
Contact: Andrei Mihailescu         
James Paget University Hospitals NHS Foundation Trust Recruiting
Great Yarmouth, United Kingdom, NR31 6LA
Contact: Christopher Liao         
Wirral University Teaching Hospital NHS Foundation Trust Recruiting
Wirral, United Kingdom, CH49 5PE
Contact: Conor Magee         
Sponsors and Collaborators
Advanced Medical Solutions Ltd.
Imarc Research, Inc.
Investigators
Layout table for investigator information
Principal Investigator: Andrei Mihailescu, MD Tameside & Glossop Integrated Care NHS Foundation Trust
More Information
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information
Layout table for additonal information
Responsible Party: Advanced Medical Solutions Ltd.
ClinicalTrials.gov Identifier: NCT04059640    
Other Study ID Numbers: OHMF-001
First Posted: August 16, 2019    Key Record Dates
Last Update Posted: September 6, 2023
Last Verified: September 2023
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Product Manufactured in and Exported from the U.S.: No
Keywords provided by Advanced Medical Solutions Ltd.:
Inguinal Hernia
Mesh Fixation
Surgical Site Wound Closure
Additional relevant MeSH terms:
Layout table for MeSH terms
Hernia
Hernia, Inguinal
Pathological Conditions, Anatomical
Hernia, Abdominal